In patients with CML, Rac1 activity was robustly higher in the BC sample (#1744) expressing Cobll1 and SH3BP1 than in the BC sample (#1919) without the expression of either Cobll1 or SH3BP. Here, RAC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.